Roche’s Evrysdi (risdiplam) is the market leader among the drugs for spinal muscular atrophy (SMA). Biogen’s Spinraza ...

As novel gene therapies emerge, there is a complex interplay among their potential benefits, the burdens they may impose and ...

Kenan R. Omurtag, M.D., discusses how less invasive fertility treatments like lifestyle modifications, ovulation induction ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

The panelist discusses how intracytoplasmic sperm injection can be used in conjunction with in vitro fertilization (IVF) to ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...